Genetically Proxied GIP‐GIPR Pathway Perturbation and Fracture Risk
To determine whether genetic proxies for incretin pathway perturbation are associated with fracture risk and bone mineral density, providing human genetic evidence relevant to the skeletal safety of incretin‐based therapies.